Answers are grounded in this paper and cite their sources.
Vascular endothelial cell growth factor (VEGF) plays a crucial role in the development of the cardiovascular system and in promoting angiogenesis associated with physiological and pathological processes. Although a great deal is known of the cytoplasmic signaling pathways activated by VEGF, much less is known of the mechanisms through which VEGF communicates with the nucleus and alters the activity of transcription factors. Binding of VEGF to the KDR/Flk1 receptor tyrosine kinase induces phosphorylation of the CRE-binding protein (CREB) transcription factor on serine 133 and increases CREB DNA binding and transactivation. p38 MAPK/MSK-1 and protein kinase C/p90RSK pathways mediate CREB phosphorylation. Confocal microscopy shows that VEGF-induced phosphorylation of nuclear CREB is blocked by pharmacological inhibition of protein kinase C and p38 mitogen-activated protein kinase signaling. Thus, KDR/Flk1 uses multiple pathways to transmit signals into the nucleus where CREB becomes activated. These results suggest that CREB may play a role in alterations of gene expression important to angiogenesis. Vascular endothelial cell growth factor (VEGF) plays a crucial role in the development of the cardiovascular system and in promoting angiogenesis associated with physiological and pathological processes. Although a great deal is known of the cytoplasmic signaling pathways activated by VEGF, much less is known of the mechanisms through which VEGF communicates with the nucleus and alters the activity of transcription factors. Binding of VEGF to the KDR/Flk1 receptor tyrosine kinase induces phosphorylation of the CRE-binding protein (CREB) transcription factor on serine 133 and increases CREB DNA binding and transactivation. p38 MAPK/MSK-1 and protein kinase C/p90RSK pathways mediate CREB phosphorylation. Confocal microscopy shows that VEGF-induced phosphorylation of nuclear CREB is blocked by pharmacological inhibition of protein kinase C and p38 mitogen-activated protein kinase signaling. Thus, KDR/Flk1 uses multiple pathways to transmit signals into the nucleus where CREB becomes activated. These results suggest that CREB may play a role in alterations of gene expression important to angiogenesis. vascular endothelial cell growth factor placental growth factor human umbilical vein endothelial cells CRE-binding protein activating transcription factor-1 mitogen activated protein kinase protein kinase C electrophoretic mobility shift assay 3-(N-morpholino)propanesulfonic acid extracellular signal-regulated kinase Angiogenesis plays an important role in embryonic development, wound healing, and organ regeneration (1Ferrara N. J. Mol. Med. 1999; 77: 527-543Crossref PubMed Scopus (1087) Google Scholar, 2Risau W. Nature. 1997; 386: 671-674Crossref PubMed Scopus (4867) Google Scholar). Angiogenesis also contributes to pathologies dependent on neovascularization, among which are tumor growth, diabetes mellitus, ischemic ocular diseases, and rheumatoid arthritis. Vascular endothelial cell growth factor (VEGF)1 is an endothelial cell-specific mitogen that promotes many other events necessary for angiogenesis (1Ferrara N. J. Mol. Med. 1999; 77: 527-543Crossref PubMed Scopus (1087) Google Scholar, 3Connolly D.T. Heuvelman D.M. Nelson R. Olander J.V. Eppley B.L. Delfino J.J. Siegel N.R. Leimgruber R.M. Feder J. J. Clin. Invest. 1989; 84: 1470-14784Crossref PubMed Scopus (1184) Google Scholar, 4Gospodarowicz D. Abraham J.A. Schilling J. Proc. Natl. Acad. Sci. U. S. A. 1989; 86: 7311-7315Crossref PubMed Scopus (555) Google Scholar, 5Keck P.J. Hauser S.D. Krivi G. Sanzo K. Warren T. Feder J. Connolly D.T. Science. 1989; 246: 1309-1312Crossref PubMed Scopus (1811) Google Scholar, 6Leung D.W. Cachianes G. Kuang W.J. Goeddel D.V. Ferrara N. Science. 1989; 246: 1306-1309Crossref PubMed Scopus (4466) Google Scholar). VEGF induces endothelial cell proliferation and movement, remodeling of the extracellular matrix, formation of capillary tubules, and vascular leakage. VEGF plays a role in the development of the cardiovascular system and in the physiology of normal vasculature (3Connolly D.T. Heuvelman D.M. Nelson R. Olander J.V. Eppley B.L. Delfino J.J. Siegel N.R. Leimgruber R.M. Feder J. J. Clin. Invest. 1989; 84: 1470-14784Crossref PubMed Scopus (1184) Google Scholar, 7Berse B. Brown L.F. Van de Water L. Dvorak H.F. Senger D.R. Mol. Biol. Cell. 1992; 3: 211-220Crossref PubMed Scopus (860) Google Scholar, 8Breier G. Albrecht U. Sterrer S. Risau W. Development. 1992; 114: 521-532Crossref PubMed Google Scholar, 9Jakeman L.B. Armanini M. Phillips H.S. Ferrara N. Endocrinology. 1993; 133: 848-859Crossref PubMed Scopus (192) Google Scholar, 10Monacci W.T. Merrill M.J. Oldfield E.H. Am. J. Physiol. 1993; 264: C995-C1002Crossref PubMed Google Scholar, 11Schweiki D. Itin A. Neufeld G. Gitay-Goren H. Keshet E. J. Clin. Invest. 1993; 91: 2235-2243Crossref PubMed Scopus (504) Google Scholar). VEGF is produced by many types of tumor cells and, by promoting vascularization, plays a significant role in the progression of cancer (12Jin Kim K. Li B. Winer J. Armanini M. Gillett N. Phillips H.S. Ferrara N. Nature. 1993; 262: 841-844Google Scholar, 13Plate K.H. Breier B. Weich H.A. Risau W. Nature. 1992; 359: 845-848Crossref PubMed Scopus (2126) Google Scholar, 14Senger D.R. Perruzzzi D.A. Feder J. Dvorak H.F. Cancer Res. 1986; 46: 5629-5632PubMed Google Scholar). VEGF exerts its actions by binding to two cell surface receptors, KDR (the human homolog of Flk1) and Flt1 (15De Vries C. Escobedo J.A. Ueno H. Houck K. Ferrara N. Williams L.T. Science. 1992; 255: 989-991Crossref PubMed Scopus (1896) Google Scholar, 16Mathews W. Jordan C.T. Gavin M. Jenkins N.A. Copeland N.G. Lemischka I.R. Proc. Natl. Acad. Sci. U. S. A. 1991; 88: 9026-9030Crossref PubMed Scopus (451) Google Scholar, 17Millauer B. Wizigmann-Voos S. Schnurch H. Martinez R. Moller N.P.H. Risau W. Ullrich A. Cell. 1993; 72: 835-846Abstract Full Text PDF PubMed Scopus (1764) Google Scholar, 18Petrova T.V. Makinen T. Alitalo K. Exp. Cell Res. 1999; 253: 117-130Crossref PubMed Scopus (241) Google Scholar, 19Quinn T.P. Peters K.G. De Vries C. Ferrara N. Williams L.T. Proc. Natl. Acad. Sci. U. S. A. 1993; 90: 7533-7537Crossref PubMed Scopus (673) Google Scholar, 20Terman B.C. Dougher-Vermazen M. Carrion M.E. Dimitrov D. Armellino D.C. Gospodarowicz D. Bohlen P. Biochem. Biophys. Res. Commun. 1992; 187: 1579-1586Crossref PubMed Scopus (1405) Google Scholar), structurally similar to members of the platelet-derived growth factor receptor family (21Shibuya M. Yamane A. Ikeda T. Tojo A. Matushime H. Sato M. Oncogene. 1990; 5: 519-524PubMed Google Scholar). Flk1 and Flt1 are essential for fetal angiogenesis, and mouse embryos null for either receptor die in utero between days 8.5 and 9.5 (22Fong G.-H. Rossant J. Gertsenstein M. Breitman M.L. Nature. 1995; 376: 66-70Crossref PubMed Scopus (2224) Google Scholar, 23Shalaby F. Rossant J. Yamaguchi T.P. Gertsenstein M. Wu X.-F. Breitman M.L. Schuh A.C. Nature. 1995; 376: 62-66Crossref PubMed Scopus (3371) Google Scholar). Hematopoietic and endothelial cell development are impaired in Flk1 null mutant mice (23Shalaby F. Rossant J. Yamaguchi T.P. Gertsenstein M. Wu X.-F. Breitman M.L. Schuh A.C. Nature. 1995; 376: 62-66Crossref PubMed Scopus (3371) Google Scholar), whereas there is overgrowth of endothelial cells and disorganized blood vessels in Flt1 null mutant mice (22Fong G.-H. Rossant J. Gertsenstein M. Breitman M.L. Nature. 1995; 376: 66-70Crossref PubMed Scopus (2224) Google Scholar). The phenotypes of Flk1- and Flt1-deficient embryos show that each plays a distinct role in angiogenesis and suggest that KDR/Flk1 and Flt1 utilize distinct signaling cascades to elicit responses. Flk1 is abundant on the proliferating endothelial cells of vascular sprouts of embryonic and early postnatal brain but is reduced in adult brains in which endothelial cell proliferation has ceased (17Millauer B. Wizigmann-Voos S. Schnurch H. Martinez R. Moller N.P.H. Risau W. Ullrich A. Cell. 1993; 72: 835-846Abstract Full Text PDF PubMed Scopus (1764) Google Scholar). Experiments with mutant forms of VEGF that selectively bind one or the other VEGF receptor show that Flk1/KDR promotes endothelial cell proliferation and survival (24Keyt B.A. Nguyen H.V. Berleau L.T. Duarte C.M. Park J. Chen H. Ferrara N. J. Biol. Chem. 1996; 271: 5638-5646Abstract Full Text Full Text PDF PubMed Scopus (424) Google Scholar). The induction of chemotaxis and procoagulant activity by VEGF and placental growth factor (PlGF), a VEGF homolog that binds Flt1, suggests that these responses are mediated, at least in part, by Flt1 (25Clauss M. Weich H. Breier G. Kniest U. Rockl W. Waltenberger J. Risau W. J. Biol. Chem. 1996; 271: 17629-17634Abstract Full Text Full Text PDF PubMed Scopus (756) Google Scholar, 26Park J.E. Chen H.H. Winer J. Houck K.A. Ferrara N. J. Biol. Chem. 1994; 269: 5646-25654Google Scholar, 27Sawano A. Takahashi T. Yamaguchi S. Aonuma M. Shibuya M. Cell Growth Differ. 1996; 7: 213-221PubMed Google Scholar). Thus, the functions of VEGF are segregated between its two receptors. In previous studies we demonstrated that VEGF promotes the tyrosine phosphorylation of signaling molecules that contain SH2 domains, and this process is associated with endothelial cell proliferation (28Guo D. Jia Q. Song H.-Y. Warren R.S. Donner D.B. J. Biol. Chem. 1995; 270: 6729-6733Abstract Full Text Full Text PDF PubMed Scopus (416) Google Scholar). By comparing signaling events induced by VEGF or PlGF, in the absence or presence of SU5416, a KDR/Flk1 antagonist (29Strawn L.M. McMahon G. App H. Schreck R. Kuchler W.R. Longhi M.P. Hui T.H. Tang C. Levitski A. Gaxrit A. Chen I. Keri G. Orfi L. Risau W. Flamme I. Ullrich A. Hirth K.P. Shawver L.K. Cancer Res. 1996; 56: 3540-3545PubMed Google Scholar), we identified signaling molecules that interact with and promote or inhibit KDR/Flk1 action (30Wu L.W. Mayo L.D. Dunbar J.D. Kessler K.M. Baerwald M.R. Jaffe E.A. Wang D. Warren R.S. Donner D.B. J. Biol. Chem. 2000; 275: 5096-5103Abstract Full Text Full Text PDF PubMed Scopus (257) Google Scholar). The present study finally identifies pathways through which cytoplasmic signaling pathways downstream of KDR/Flk1 transmit signals into the nucleus. VEGF promotes phosphorylation and activation of the cyclic AMP-responsive element-binding protein by activation of p38 mitogen-activated protein kinase/MSK-1 and protein kinase C/p90RSK signaling pathways downstream of KDR. As CREB is a transcription factor that plays an important role in promoting proliferation and cellular adaptive responses (31Shaywitz A.J. Greenberg M.E. Annu. Rev. Biochem. 1999; 68: 821-861Crossref PubMed Scopus (1797) Google Scholar), a mechanism has been defined through which VEGF/KDR may allow endothelial cells to respond to changes in their environment through alterations of gene expression. Human recombinant VEGF was a gift from Genentech (South San Francisco, CA). SU5416 was a gift from SUGEN, Inc. (South San Francisco, CA). Placenta growth factor and VEGF-D were from R & D Laboratories (Minneapolis, MN). Antibodies to phosphorylated CREB/ATF-1, phosphorylated MSK-1, phosphorylated and non-phosphorylated p38 MAPK, and MAPK were from Cell Signaling Technology (Beverly, MA). Anti-MAPKAP kinase 2 and recombinant ATF-1 were from Santa Cruz Biotechnology (Santa Cruz, CA). Anti-MAPKAP kinase 3 was from Upstate Biotechnology, Inc. (Lake Placid, NY). PGAL4-CREB was from Stratagene (La Jolla, CA), and the GAL4 luciferase reporter construct was a kind gift of Dr. Lawrence Quilliam (Indiana University School of Medicine). GF109203X was from LC Laboratories (Boston). All other were from or were on in endothelial cell growth San at VEGF the cells were in endothelial cell that was with the cells were with in the and with VEGF for were into that was with and on for from each was by and to The were blocked in in Antibodies to the were p38 MAPK, MAPK, and CREB Signaling MA). on the were the cell were from with or VEGF for In or were from of cell at 2 of an to each was and for the were with kinase assay and this was The was for at in of kinase assay to contain and of recombinant were on and were with to phosphorylated or protein were the by cell and to the of the The and mutant DNA were from Santa Cruz Biotechnology, Inc. The was with the kinase and by through formation of of each nuclear binding and and of in a of were on for and of was to the which was for an The was on a The was and to gene reporter cells were with and of the DNA binding of and the of and expression for the luciferase reporter gene by the kinase to of the luciferase activity was in cell and to expression. with or GF109203X for and with VEGF for were with and blocked with was by a The nucleus was by with nuclear of the was on a Experiments were to VEGF induces CREB phosphorylation and and, to the receptor through which this is were with VEGF, and a from cell was with an CREB phosphorylated on serine VEGF induced CREB phosphorylation in a to the between CREB and ATF-1 (31Shaywitz A.J. Greenberg M.E. Annu. Rev. Biochem. 1999; 68: 821-861Crossref PubMed Scopus (1797) Google Scholar), the also phosphorylated serine of The phosphorylation CREB and ATF-1 in which VEGF receptor was for CREB and ATF-1 were with VEGF or PlGF, which binds Flt1 J.E. Chen H.H. Winer J. Houck K.A. Ferrara N. J. Biol. Chem. 1994; 269: 5646-25654Google Scholar, 27Sawano A. Takahashi T. Yamaguchi S. Aonuma M. Shibuya M. Cell Growth Differ. 1996; 7: 213-221PubMed Google Scholar). VEGF, but PlGF, induced CREB that KDR induced this SU5416, a KDR antagonist (29Strawn L.M. McMahon G. App H. Schreck R. Kuchler W.R. Longhi M.P. Hui T.H. Tang C. Levitski A. Gaxrit A. Chen I. Keri G. Orfi L. Risau W. Flamme I. Ullrich A. Hirth K.P. Shawver L.K. Cancer Res. 1996; 56: 3540-3545PubMed Google Scholar), VEGF-induced CREB and ATF-1 phosphorylation. the that Flt1 contributes to activation of of the VEGF family bind Flt1 M. E. Makinen T. A. Alitalo K. Proc. Natl. Acad. Sci. U. S. A. PubMed Scopus Google Scholar), was and to phosphorylation of CREB and ATF-1 of serine 133 in CREB the DNA binding of CREB to but increases its with the to activation of the that of with VEGF to phosphorylation of CREB downstream of KDR to CREB activity was by gene reporter assay in which were with and a luciferase reporter construct demonstrated that VEGF induces a of CREB activation Experiments were to the signaling pathways that CREB phosphorylation. By of with to activated MAPK and and p38 MAPK, we that VEGF these each of these with activation and activation of MAPK family members was by signaling through were in the absence or presence of SU5416 and with VEGF or The KDR antagonist VEGF activation of p38 MAPK and and that the are activated through KDR signaling. is with the of to p38 MAPK or MAPK and MAPK and MAPK are activated by signaling through KDR. in the absence or presence of SU5416 were with a was with MAPK and with MAPK a was with and with MAPK, or p38 MAPK, plays a role in CREB were with a MAPK kinase that MAPK activation D.T. L. A.J. Proc. Natl. Acad. Sci. U. S. A. 1995; PubMed Scopus Google Scholar), or an of p38 MAPK A. J. R. P. 1995; PubMed Scopus Google Scholar), and with CREB phosphorylation induced by VEGF was by inhibition of MAPK by p38 MAPK inhibition CREB phosphorylation that this of the MAPK family plays a role in VEGF activation of other to CREB activation by were with an of an of protein kinase an of kinase or an of protein kinase C D. P. H. P. T. M. P. E. F. J. Biol. Chem. 1991; Scholar). and were in the and and CREB phosphorylation induced by VEGF, whereas GF109203X phosphorylation of cells with GF109203X and that inhibition of and p38 MAPK on CREB phosphorylation but blocked VEGF-induced phosphorylation the downstream kinase that CREB phosphorylation induced by were with or and with VEGF from cell was with an to phosphorylated a CREB kinase downstream of VEGF phosphorylation and this was by but that a is a of the mechanism through which VEGF induces CREB phosphorylation. kinase kinase and are CREB and ATF-1 activated by p38 MAPK M. L.M. D.R. J. PubMed Scopus Google Scholar, R. J. 1996; PubMed Scopus Google Scholar, J. A. C. P. M.J. J. 1996; PubMed Scopus Google Scholar, J. E.A. Greenberg M.E. Mol. Cell. Biol. PubMed Google Scholar). As to phosphorylated forms of each of these CREB are their activation was by an in kinase assay in which ATF-1 was the were with or VEGF, and kinase kinase or were from cell and with was with an to phosphorylated and, of the VEGF activated were with or to inhibit and p38 MAPK and with from cell was with ATF-1 and a with and with VEGF induced phosphorylation of ATF-1 and MSK-1, and this was blocked by inhibition of p38 MAPK but suggests that activation of p38 is a of a signaling through which VEGF induces CREB phosphorylation. Confocal microscopy was to a between phosphorylation of CREB on serine 133 and DNA binding of the transcription were with VEGF or with of and p38 MAPK and with Confocal microscopy that nuclear phosphorylation of CREB was induced by VEGF, and this was by pharmacological of the p38 MAPK and signaling cascades CREB binds to the known electrophoretic mobility shift assay that of with VEGF induced the formation of a The was of but mutant with and that CREB was a of the induced by VEGF that KDR was the receptor for induction of were with SU5416 with CREB DNA binding was of to SU5416, that KDR is for activation of CREB Angiogenesis the expression of gene that allow endothelial cells to their and W. Nature. 1997; 386: 671-674Crossref PubMed Scopus (4867) Google Scholar). wound healing, or pathological tumor growth, that the cells from a to an W. Nature. 1997; 386: 671-674Crossref PubMed Scopus (4867) Google Scholar). the is by of VEGF and its receptors, of of angiogenesis, or types of events G. Albrecht U. Sterrer S. Risau W. Development. 1992; 114: 521-532Crossref PubMed Google Scholar, 9Jakeman L.B. Armanini M. Phillips H.S. Ferrara N. Endocrinology. 1993; 133: 848-859Crossref PubMed Scopus (192) Google Scholar, 11Schweiki D. Itin A. Neufeld G. Gitay-Goren H. Keshet E. J. Clin. Invest. 1993; 91: 2235-2243Crossref PubMed Scopus (504) Google Scholar, 17Millauer B. Wizigmann-Voos S. Schnurch H. Martinez R. Moller N.P.H. Risau W. Ullrich A. Cell. 1993; 72: 835-846Abstract Full Text PDF PubMed Scopus (1764) Google Scholar, M. A. Donner D.B. L. Warren R.S. Oncogene. PubMed Scopus Google Scholar, D. Donner D.B. Warren R.S. J. Biol. Chem. 2000; 275: Full Text Full Text PDF PubMed Scopus Google Scholar, R.S. H. M.R. Ferrara N. Donner D.B. J. Biol. Chem. 1996; 271: Full Text Full Text PDF PubMed Scopus Google Scholar). VEGF-induced angiogenesis to by blocked blood and inhibition of VEGF and its the progression of cancer (1Ferrara N. J. Mol. Med. 1999; 77: 527-543Crossref PubMed Scopus (1087) Google Scholar, Kim K. Li B. Winer J. Armanini M. Gillett N. Phillips H.S. Ferrara N. Nature. 1993; 262: 841-844Google Scholar, 19Quinn T.P. Peters K.G. De Vries C. Ferrara N. Williams L.T. Proc. Natl. Acad. Sci. U. S. A. 1993; 90: 7533-7537Crossref PubMed Scopus (673) Google Scholar, B. Shawver L.K. K.H. Risau W. Ullrich A. Nature. 1994; PubMed Scopus Google Scholar, R.S. H. M.R. Gillett N.A. Ferrara N. J. Clin. Invest. 1995; PubMed Scopus Google Scholar). from this and previous studies (30Wu L.W. Mayo L.D. Dunbar J.D. Kessler K.M. Baerwald M.R. Jaffe E.A. Wang D. Warren R.S. Donner D.B. J. Biol. Chem. 2000; 275: 5096-5103Abstract Full Text Full Text PDF PubMed Scopus (257) Google Scholar, H. I. J. Biol. Chem. 1997; PubMed Scopus Google Scholar, A. J. M. B.A. Ferrara N. J. Biol. Chem. Full Text Full Text PDF PubMed Scopus Google are in the in which shows that by signaling through VEGF induces activation of MAPK, p38 MAPK, and tyrosine phosphorylation of and kinase is associated with cell whereas and MAPK signaling promote cell survival M. D. J. Biol. Chem. 1997; Full Text Full Text PDF PubMed Scopus Google Scholar). MAPK also promotes the of endothelial cells to VEGF (30Wu L.W. Mayo L.D. Dunbar J.D. Kessler K.M. Baerwald M.R. Jaffe E.A. Wang D. Warren R.S. Donner D.B. J. Biol. Chem. 2000; 275: 5096-5103Abstract Full Text Full Text PDF PubMed Scopus (257) Google Scholar). KDR/Flk1 binds a which may that contain SH2 to the receptor L.W. Mayo L.D. Dunbar J.D. Kessler K.M. Warren R.S. Donner D.B. J. Biol. Chem. 2000; 275: Full Text Full Text PDF PubMed Scopus Google and the protein tyrosine Wu Dunbar J.D. Mayo L.D. Kessler K.M. J.A. Baerwald M.R. Jaffe E.A. Warren R.S. Donner D.B. J. Biol. Chem. 2000; 275: Full Text Full Text PDF PubMed Scopus Google Scholar). The of associated with KDR/Flk1 is by tumor that the activity of this receptor and its with signaling is by Wu Dunbar J.D. Mayo L.D. Kessler K.M. J.A. Baerwald M.R. Jaffe E.A. Warren R.S. Donner D.B. J. Biol. Chem. 2000; 275: Full Text Full Text PDF PubMed Scopus Google Scholar). of endothelial cells KDR/Flk1 or Flt1 with VEGF induces of the but the receptor with and J. Waltenberger J. J. Biol. Chem. 1997; Full Text Full Text PDF PubMed Scopus Google Scholar, J. L. A. Shibuya M. J. Biol. Chem. 1994; 269: Scholar). MAPK changes of cell and cell proliferation are also induced by signaling through These between KDR/Flk1 and Flt1 were in studies with cells with these L. N. Neufeld G. Yamaguchi S. Shibuya M. Oncogene. 1995; Google Scholar, T. Shibuya M. Oncogene. 1997; PubMed Scopus Google Scholar, A. Greenberg M.E. Cell. 1994; 77: Full Text PDF PubMed Scopus Google or in in which Flt1 was to from cell N. C. U. L. J. Biol. Chem. Full Text Full Text PDF PubMed Scopus Google Scholar). the of from that KDR/Flk1 is a of VEGF action in the whereas the role of Flt1 to Thus, has been into cytoplasmic events by VEGF in of its less is known of VEGF induces changes of gene expression that angiogenesis. CREB is a of the family of nuclear transcription that was identified a of cyclic gene expression M.R. L.M. Nature. PubMed Scopus Google Scholar). of CREB is by phosphorylation of serine 133 M.R. Cell. 1989; Full Text PDF PubMed Scopus Google Scholar), which gene transcription A. Greenberg M.E. Cell. 1994; 77: Full Text PDF PubMed Scopus Google Scholar). growth and of surface CREB J. A. C. P. M.J. J. 1996; PubMed Scopus Google Scholar, A. Greenberg M.E. Cell. 1994; 77: Full Text PDF PubMed Scopus Google Scholar, H. K. Cell. 1995; Full Text Full Text PDF Scopus Google Scholar, M. G. E. M. S. P. R. Cell Growth Differ. 1995; Google Scholar, M. K. T. W. C. K. M. P. J. 1996; Scopus Google Scholar, H. J. 1995; Google Scholar). of and the signaling through which these cellular that serine 133 in CREB may a for a of protein phosphorylation with of which induces activation of the an of MAPK of the MAPK are the MAPK and which in play a role in activation of kinase a CREB kinase D. S. A. P. Proc. Natl. Acad. Sci. U. S. A. PubMed Scopus Google Scholar). p38 MAPK and its downstream and are of an to CREB activation M. L.M. D.R. J. PubMed Scopus Google Scholar, R. J. 1996; PubMed Scopus Google Scholar, J. A. C. P. M.J. J. 1996; PubMed Scopus Google Scholar, J. E.A. Greenberg M.E. Mol. Cell. Biol. PubMed Google Scholar). that CREB are a of which is activated by and protein kinase C H. J. 1995; Google P. H. 1994; PubMed Scopus Google Scholar, M. Greenberg M.E. Science. 1991; PubMed Scopus Google Scholar, J. Greenberg M.E. Science. 1996; PubMed Scopus Google Scholar). The present study has that VEGF increases phosphorylation of nuclear CREB on serine 133 and increases CREB DNA binding and transactivation. Thus, of the that VEGF The of VEGF and but PlGF, to CREB phosphorylation shows that is by signaling through KDR that CREB activation is is by the of SU5416 to CREB activation by Thus, one of the two VEGF plays a role in the induction of CREB and protein kinase and kinase were of VEGF-induced CREB phosphorylation on the of and to inhibit VEGF-induced CREB phosphorylation. of p38 MAPK by VEGF-induced activation of an of of CREB activation was p38 MAPK and were These results show that p38 MAPK and mediate CREB phosphorylation downstream of KDR. CREB plays an important role in cell adaptive and (31Shaywitz A.J. Greenberg M.E. Annu. Rev. Biochem. 1999; 68: 821-861Crossref PubMed Scopus (1797) Google Scholar, L. Annu. Rev. Biochem. 1997; PubMed Scopus Google Scholar). In CREB is for the of a normal of cell development, and the absence of CREB to and in the adult K. N. M. C. C. Nature. 1996; PubMed Scopus Google Scholar, R.M. H. J. Clin. Invest. PubMed Scopus Google Scholar, R.S. C. M.R. Nature. 1991; PubMed Scopus Google Scholar). CREB family members are important for and and to the to of A.J. S. Annu. Rev. PubMed Scopus Google Scholar, J.A. R. J. Mol. Med. PubMed Scopus Google Scholar). suggest that by cellular responses to VEGF, CREB is to play an important role in endothelial cell and blood
No takes yet. Share an insight, caveat, or question.
Mayo et al. (2001) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: